Latest stories on XERS
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 | XERS Stock News
StockTitan50 · neutralgeneral
Xeris Biopharma Eliminates 2028 Convertible Notes Via Exchanges
TipRanks63 · neutralgeneral
Xeris Biopharma Holdings, Inc. (XERS) files 8-K
SEC 8-K50 · neutralgeneral
These low-priced stocks are flashing overbought signals
Seeking Alpha48 · neutralgeneral
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | XERS Stock News
StockTitan50 · neutralgeneral
Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | XERS Stock News
StockTitan50 · neutralgeneral
Xeris Biopharma Holdings, Inc. (XERS) files 8-K
SEC 8-K50 · neutralgeneral
Xeris Announces Updates to Its Board of Directors | XERS Stock News
StockTitan50 · neutralgeneral
Jim Cramer Blesses a Caller’s Speculative Investment in Xeris Biopharma
Yahoo Top56 · neutralgeneral
Xeris Biopharma Announces Debt Reduction via Note Exchanges
TipRanks59 · neutralgeneral
Xeris to retire $23M of convertible notes through exchange agreements
Seeking Alpha42 · neutralgeneral
Xeris Biopharma Holdings, Inc. (XERS) files 8-K
SEC 8-K50 · neutralgeneral
Xeris Biopharma Announces Private Exchange of Convertible Notes | XERS Stock News
StockTitan63 · neutralgeneral
Xeris Biopharma Shareholders Elect Directors and Ratify Auditor
TipRanks50 · neutralgeneral
These low-priced stocks are flashing overbought signals
Seeking Alpha48 · neutralgeneral
Xeris Looks Ridiculously Cheap If Growth Forecasts Are Even Halfway Right
Seeking Alpha67 · bullishanalyst
Xeris Biopharma Q1 Earnings Call Highlights
Yahoo Top68 · bullishearnings
Xeris (XERS) Q1 2026 Earnings Call Transcript
Yahoo Finance67 · bullishearnings